Treponema denticola cytoskeletal filaments and oral infection
Project Number1R21DE017106-01A1
Contact PI/Project LeaderIZARD, JACQUES G
Awardee OrganizationADA FORSYTH INSTITUTE, INC.
Description
Abstract Text
DESCRIPTION (provided by applicant): Among the key pathogens involved in oral bacterial diseases, Treponema denticola is the most invasive organism. The various oral Treponema bacterial species have in common a cytoplasmic structure with organizational similarities to intermediate filaments. In vitro experiments have demonstrated the importance of such structure in key events related to oral infectivity. The goal of this research is to decipher the importance and function of treponemal intermediate-like filaments in pathogenicity in vivo. The long-term goal is to develop new strategies to combat the invasive nature of treponemal cells, while maintaining a healthy oral microbiota. The rationale is to validate the hypothesis that treponemes propagation (colonization, persistence, and dissemination first local and then systemic) is dependent upon intermediate- like filaments. The proposed studies will focus on testing the pathogenicity of a genetically engineered T. denticola mutant deficient in intermediate-like filaments (cfpA knockout) in appropriate animal models to study oral infections. The infectivity of the cfpA knockout mutant will be tested in two mouse models. The first mouse model investigates the tissue and bone damage associated with an endodontic infection (Aim 1). The second mouse model tests the pathogenicity in a periodontal infection (Aim 2). In conjunction with the cfpA knockout mutant, the wild-type strain (live and formalin-killed) will be used as control, as well as a mutant deficient in motility to test the effect of live antigen presentation during the colonization step. The experimental quantitative endpoint is the measurement of bone loss at the root of the infected tooth in the endodontic model, and the recession of the alveolar bone crest from the cementoenamel junction in the periodontal model. A qualitative criterion is the inflammation associated with the infection, which is to be evaluated by histology of the center plane of the infected tooth in the endodontic infection model, and by cytokine production in the periodontal infection model. In the case of the periodontal infection model, an additional criterion will be the modification of the oral microbiota post-infection. This study will further our understanding of the pathogenesis of T. denticola in both periodontal and endodontic infections by providing a more complete understanding of the role of intermediate-like filaments in infectivity, the importance of motility for treponemes persistence, and model the biofilm population changes associated with periodontal disease. To allow the modulation of the oral biofilm, clinicians need new strategies to fight periodontal diseases. New strategies rely on an understanding of microbial biology. To limit bone loss and other damages, proper host responses and healthy natural biofilm should be promoted in the patient healing process. Our strategy is to target key functional entities of aggressive and invasive pathogens, with the goal of eliminating the damage- inducing population.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
062190616
UEI
MZ9DFVC2J1B7
Project Start Date
01-April-2007
Project End Date
28-February-2009
Budget Start Date
01-April-2007
Budget End Date
29-February-2008
Project Funding Information for 2007
Total Funding
$241,050
Direct Costs
$150,000
Indirect Costs
$91,050
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Dental and Craniofacial Research
$241,050
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21DE017106-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21DE017106-01A1
Patents
No Patents information available for 1R21DE017106-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21DE017106-01A1
Clinical Studies
No Clinical Studies information available for 1R21DE017106-01A1
News and More
Related News Releases
No news release information available for 1R21DE017106-01A1
History
No Historical information available for 1R21DE017106-01A1
Similar Projects
No Similar Projects information available for 1R21DE017106-01A1